Topic
Drug Labeling
96 published works
Constitutional Law Prof Blog
FDA Staff Objected to Preemption
By ConLawProf initials at end of post
The House Oversight and Government Reform Committee released a report and supporting documents yesterday showing that career FDA staff objected to FDA drug labelling requirements preempting state consumer lawsuits against…
TortsProf Blog
The FDA’s New CBE Rule
The FDA issued a new final rule [PDF] relating to "changes being effected" -- i.e., changes that a drug manufacturer can make to its label without advance permission. The focus…
Drug & Device Law
The New CBE Rule Is Final
By Bexis
The FDA has finalized the new CBE rule. (That's the so-called "Change Being Effected" rule at 21 C.F.R. Sec. 314.70(c)(6) for drugs.) Here was our post on that subject when…
Mass Tort Litigation Blog
Gearing up for Wyeth v. Levine
By joetort
This morning's Wall Street Journal has a preview of the two sides and the politics involved in Wyeth v. Levine, which will be argued before the Supreme Court on November…
Mass Tort Defense
Government Files Amicus Brief in Levine v. Wyeth
By Sean Wajert
For those readers of MassTortDefense following the Levine v. Wyeth matter, here is the BRIEF FOR THE UNITED STATES AS AMICUS CURIAE SUPPORTING PETITIO
Health Industry Washington Watch
FDA Rule on Drug Label Pregnancy Information
On May 29, 2008, the Food and Drug Administration (FDA) published a proposed rule to make major revisions to drug label requirements related to the use of a drug during…
Drug & Device Law
FDA Proposed Pregnancy/Lactation Rule Discusses Preemption
By Bexis
The other day the FDA proposed a rule to revise those aspects of drug labeling dealing with pregnancy and childbirth. The FDA Law Blog has a good description of the…
Drug & Device Law
The Future is Now
By Bexis
We suspect most readers of this blog are living the same lives we are: We've now submitted either the Supreme Court's decision in Riegel or the Third Circuit's decision in…
Health Industry Washington Watch
FDA Labeling Change Requirements
The FDA has published a proposed rule to codify the agency's views on when a change to the labeling of an approved drug, biologic, or medical device may be made…
Louisiana Law Blog
Vioxx Multidistrict Litigation Court Refuses to Give Deference to FDA’s Preemption Preamble
By Glenn Farnet
On January 24, 2006, the U.S. Food and Drug Administration (FDA) issued a Final Rule entitled Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products,…